JP2018518153A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518153A5 JP2018518153A5 JP2017552899A JP2017552899A JP2018518153A5 JP 2018518153 A5 JP2018518153 A5 JP 2018518153A5 JP 2017552899 A JP2017552899 A JP 2017552899A JP 2017552899 A JP2017552899 A JP 2017552899A JP 2018518153 A5 JP2018518153 A5 JP 2018518153A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- binding fragment
- antigen
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021200631A JP7456989B2 (ja) | 2015-04-07 | 2021-12-10 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
| JP2024039804A JP7741225B2 (ja) | 2015-04-07 | 2024-03-14 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562144251P | 2015-04-07 | 2015-04-07 | |
| US62/144,251 | 2015-04-07 | ||
| US201662307645P | 2016-03-14 | 2016-03-14 | |
| US62/307,645 | 2016-03-14 | ||
| PCT/US2016/026352 WO2016164528A1 (en) | 2015-04-07 | 2016-04-07 | Anti-flt-1 antibodies for treating duchenne muscular dystrophy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200631A Division JP7456989B2 (ja) | 2015-04-07 | 2021-12-10 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518153A JP2018518153A (ja) | 2018-07-12 |
| JP2018518153A5 true JP2018518153A5 (enExample) | 2019-05-16 |
| JP6993880B2 JP6993880B2 (ja) | 2022-01-14 |
Family
ID=55754471
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552899A Active JP6993880B2 (ja) | 2015-04-07 | 2016-04-07 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
| JP2021200631A Active JP7456989B2 (ja) | 2015-04-07 | 2021-12-10 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
| JP2024039804A Active JP7741225B2 (ja) | 2015-04-07 | 2024-03-14 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200631A Active JP7456989B2 (ja) | 2015-04-07 | 2021-12-10 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
| JP2024039804A Active JP7741225B2 (ja) | 2015-04-07 | 2024-03-14 | デュシェンヌ型筋ジストロフィーの治療における抗ｆｌｔ－１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US10787515B2 (enExample) |
| EP (2) | EP4056593A1 (enExample) |
| JP (3) | JP6993880B2 (enExample) |
| CN (3) | CN107787330B (enExample) |
| AU (2) | AU2016246722B2 (enExample) |
| ES (1) | ES2910783T3 (enExample) |
| MA (1) | MA41899A (enExample) |
| MX (1) | MX2017012828A (enExample) |
| PL (1) | PL3280734T3 (enExample) |
| WO (1) | WO2016164528A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41899A (fr) | 2015-04-07 | 2018-02-13 | Shire Human Genetic Therapies | Anticorps anti-flt-1 pour traiter la dystrophie musculaire de duchenne |
| US20230287122A1 (en) * | 2018-11-29 | 2023-09-14 | Harbour Biomed Therapeutics Limited | Anti-pd-l1 antibody preparation |
| MY208487A (en) * | 2019-08-02 | 2025-05-13 | Cttq Akeso Shanghai Biomed Tech Co Ltd | Anti-pd-1 antibody and medical use thereof |
| CN114230666B (zh) * | 2021-12-20 | 2022-09-02 | 南京诺唯赞生物科技股份有限公司 | 一种t7 rna聚合酶的单克隆抗体及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8287864B2 (en) * | 2002-02-14 | 2012-10-16 | Immunomedics, Inc. | Structural variants of antibodies for improved therapeutic characteristics |
| EP2377555A3 (en) | 2004-11-18 | 2011-11-23 | Imclone LLC | Antibodies against vascular endothelial growth factor receptor-1 |
| US8858940B2 (en) | 2008-12-10 | 2014-10-14 | Ablynx N.V. | Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis |
| JP6169495B2 (ja) * | 2011-02-07 | 2017-07-26 | アガミン・エルエルシー | 妊娠関連高血圧性障害を治療または予防するための方法およびシステム |
| EA037501B1 (ru) * | 2013-01-28 | 2021-04-05 | Шир Хьюман Дженетик Терапис, Инк. | Способ лечения мышечной дистрофии дюшенна путем введения анти-flt-1-антитела |
| TW201517916A (zh) * | 2013-03-15 | 2015-05-16 | Lilly Co Eli | Ｖｅｇｆｒ１抗體之治療用途 |
| MA41899A (fr) | 2015-04-07 | 2018-02-13 | Shire Human Genetic Therapies | Anticorps anti-flt-1 pour traiter la dystrophie musculaire de duchenne |
-
2016
- 2016-04-06 MA MA041899A patent/MA41899A/fr unknown
- 2016-04-07 US US15/564,976 patent/US10787515B2/en active Active
- 2016-04-07 MX MX2017012828A patent/MX2017012828A/es unknown
- 2016-04-07 PL PL16716795T patent/PL3280734T3/pl unknown
- 2016-04-07 EP EP22153298.9A patent/EP4056593A1/en active Pending
- 2016-04-07 AU AU2016246722A patent/AU2016246722B2/en active Active
- 2016-04-07 EP EP16716795.6A patent/EP3280734B1/en active Active
- 2016-04-07 ES ES16716795T patent/ES2910783T3/es active Active
- 2016-04-07 CN CN201680032814.0A patent/CN107787330B/zh active Active
- 2016-04-07 JP JP2017552899A patent/JP6993880B2/ja active Active
- 2016-04-07 CN CN202510178279.0A patent/CN120290577A/zh active Pending
- 2016-04-07 CN CN202210037246.0A patent/CN114539408B/zh active Active
- 2016-04-07 WO PCT/US2016/026352 patent/WO2016164528A1/en not_active Ceased
-
2020
- 2020-08-12 US US16/991,762 patent/US20210206860A1/en not_active Abandoned
-
2021
- 2021-12-10 JP JP2021200631A patent/JP7456989B2/ja active Active
-
2022
- 2022-01-25 AU AU2022200466A patent/AU2022200466B2/en active Active
-
2023
- 2023-03-23 US US18/189,065 patent/US12435146B2/en active Active
-
2024
- 2024-03-14 JP JP2024039804A patent/JP7741225B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019205936B2 (en) | Methods for treating IL-6 mediated inflammation without immunosuppression | |
| JP2018510617A5 (enExample) | ||
| JP2014158469A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| JP2019513726A5 (enExample) | ||
| US12312400B2 (en) | Engineered anti-il-2 antibodies | |
| JP2016519650A5 (enExample) | ||
| CN110799543A (zh) | 肝细胞癌的免疫治疗 | |
| JP2015506945A5 (enExample) | ||
| JP2013544078A5 (enExample) | ||
| JP2016505546A5 (enExample) | ||
| JP2018518153A5 (enExample) | ||
| JP2018536632A5 (ja) | Ｂ７‐ｈ３に特異的に結合する分子及びｐｄ‐１に特異的に結合する分子 | |
| CN112351794A (zh) | 用于尿路上皮癌的免疫治疗方法 | |
| JP2022553129A (ja) | ポリオウイルス受容体（ｐｖｒ）に対する抗体およびその使用 | |
| JP7698635B2 (ja) | 抗幹細胞因子抗体及びその使用方法 | |
| TW202216763A (zh) | 治療心血管疾病之方法 | |
| JP2023504531A (ja) | 腫瘍治療のための二重特異性融合タンパク質と抗Ｈｅｒ２抗体の組合せ | |
| JP2017501182A5 (enExample) | ||
| JP2018517667A5 (enExample) | ||
| TWI825687B (zh) | 抗ｃｘｃｒ２抗體及其用途 | |
| US20240287169A1 (en) | Methods of use of anti-il-2 antibodies | |
| US20240279329A1 (en) | Methods of use of anti-il-2 antibodies | |
| TW202537974A (zh) | Ｔｒｇｖ９結合蛋白及其醫藥用途 | |
| CN120225557A (zh) | 特异于跨膜激活物和caml相互作用物(taci)的抗原结合蛋白 |